Which Features of the Metabolic Syndrome Predict the Prevalence and Clinical Outcomes of Angiographic Coronary Artery Disease?

Cardiology

Volumn 101, Issue 4, 2004, Pages 185-193

  Anderson, Jeffrey L ^a,b   Horne, Benjamin D ^a   Jones, Heath U ^a   Reyna, Sandra P ^a   Carlquist, John F ^a   Bair, Tami L ^a   Pearson, Robert R ^a   Lappé, Donald L ^a   Muhlestein, Joseph B ^a  

^a UNIVERSITY OF UTAH   (United States)

^b LDS HOSPITAL   (United States)

Author keywords

Coronary artery disease; Diabetes; Metabolic syndrome; Prevention; Risk

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY BLOOD VESSEL; CORONARY RISK; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HAZARD ASSESSMENT; HEART DEATH; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HUMAN; KIDNEY FAILURE; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BLOOD GLUCOSE; CHOLESTEROL, HDL; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES;

EID: 1542286723     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076695     Document Type: Article

References (42)

1. Eckel RH, Barouch WW, Ershow AG: Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the Pathophysiology of Obesity-Associated Cardiovascular Disease. Circulation 2002;105:2923-2928.
2. Grundy SM: Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002;105:2696-2698.
3. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
5. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP: Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes Care 1992;41:715-722.
6. de Vegt F, Dekker J, Jager A, et al: Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA 2001;285:2109-2113.
7. Trevisan M, Liu J, Bahsas FB, Menotti A: Syndrome X and mortality: A population-based study. Am J Epidemiol 1998;148:958-966.
8. Isomaa B, Almgren P, Tuomi T, et al: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
9. Lakka H-M, Laaksonen DE, Lakka TA, et al: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716.
10. Ridker PM, Buring JE, Cook NR, Rifai N: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women. Circulation 2003;107:391-397.
11. Taylor GS, Muhlestein JB, Wagner GS, et al: Implementation of a computerized cardiovascular information system in a private hospital setting. Am Heart J 1998;136:792-803.
12. Muhlestein JB, Quigley PJ, Ohman EM, et al: Prospective analysis of possible myocardial damage or hemolysis occurring as a result of prolonged autoperfusion angioplasty in humans. J Am Coll Cardiol 1992;20:594-598.
13. American Diabetes Association: Diabetes Vital Statistics 1996. Alexandria, American Diabetes Association, 1996, vol 4.
14. American Diabetes Association: Report of the Expert Committee on the Diagnosis and Classification of diabetes mellitus. Diabetes Care 1997;20:1183-1197.
15. Horne BD, Muhlestein JB, Allen-Maycock CA, et al: Inadequate prediction of death by the Framingham risk model for patients with existing, angiographically-defined coronary artery disease. J Am Coll Cardiol 2002;39:441A.
16. Sattar N, Gaw A, Scherbakova O, et al: Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-419.
17. Muhlestein JB, Anderson JL, Horne BD, et al: Effect of fasting glucose levels on mortality in non-diabetic and diabetic patients with coronary artery disease undergoing percutaneous coronary intervention. Am Heart J 2003;146:351-358.
18. Tominaga M, Eguchi H, Manaka H, et al: Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. Diabetes Care 1999;22:920-924.
19. Fisman EZ, Motro M, Tenenbaum A, et al: Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: A marker for a worse prognosis. Am Heart J 2001;141:485-490.
20. Lebovitz HE: Insulin resistance: Definition and consequences. Exp Clin Endocrinol Diabetes 2001;109:S135-S148.
21. Meigs JB: Invited commentary: Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000;152:908-911.
22. Reaven G: Metabolic syndrome. Pathophysiology and implications for management of cardiovascular disease. Circulation 2002;106:286.
23. Mitchell BD, Kammerer CM, Mahaney MC, et al: Genetic analysis of the insulin resistance syndrome: Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures. Arterioscler Thromb Vasc Biol 1996;16:281-288.
24. Svenson KL, Bogue MA, Peters LL: Invited review: Identifying new mouse models of cardiovascular disease: A review of high-throughput screens of mutagenized and inbred strains. J Appl Physiol 2003;94:1650-1659.
25. Cox NJ: Calpain 10 and genetics of type 2 diabetes. Curr Diab Rep 2002;2:186-190.
26. Francke S, Manraj M, Lacquemant C, et al: A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet 2001;10:2751-2765.
27. Mercado MM, McLenithan JC, Silver KD, Shuldiner AR: Genetics of insulin resistance. Curr Diab Rep 2002;2:83-95.
28. Hauser ER, Mooser V, Crossman DC, et al: Design of the Genetics of Early Onset Cardiovascular Disease (GENECARD) study. Am Heart J 2003;145:602-613.
29. von Eckardstein A, Nofer JR, Assman G: High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 2001;21:13-27.
30. Tall AR, Jiang X, Luo Y, Silver KD: 1999 George Lyman Duff Memorial Lecture: Lipid transfer proteins, high density lipoprotein metabolism and atherogenesis. Arterioscler Thromb Vasc Biol 2000;20:1135-1138.
31. Libby P: Managing the risk of atherosclerosis: The role of high density lipoprotein. Am J Cardiol 2001;88:3N-8N.
32. Betteridge DJ, Illingworth DR, Shepherd J: Lipoproteins in Health and Disease. London, Arnold, 1999.
33. Brown BG, Cheung MC, Lee AC, Zhao XQ, Chait A: Antioxidant vitamins and lipid therapy. End of a long romance? Arterioscler Thromb Vasc Biol 2002;22:1535-1546.
34. Haffner SM, Stern MP, Hazuda HP, et al: Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990;263:2893-2898.
35. Grundy SM, Howard B, Smith SJ, Eckel RH, Redberg R, Bonow RO: Prevention Conference VI: Diabetes and Cardiovascular Disease: Executive summary: Conference proceedings for healthcare professionals from a special writing group of the American Heart Association. Circulation 2002;105:2231-2239.
36. Gerstein HC, Yusuf S: Dysglycaemia and risk of cardiovascular disease. Lancet 1996;347:949-950.
37. Haffner SM: Epidemiology of insulin resistance and its relation to coronary artery disease. Am J Cardiol 1999;84:11J-14J.
38. Wingard DL, Barrett-Connor E, Ferrara A: Is insulin really a heart disease risk factor? Diabetes Care 1995;18:1299-1304.
39. Kannel WB, McGee DL: Diabetes and cardiovascular disease: The Framingham Study. JAMA 1979;241:2035-2038.
40. Stamler J, Vaccaro O, Neaton JD, et al: Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-444.
41. Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH: A prospective study of coronary heart disease in relation to fasting insulin, glucose and diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 1997;20:935-942.
42. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-234.